|Up a level|
Arivazhagan, A and Kumar, Durairaj Mohan and Sagar, Vinay and Patric, Irene Rosita Pia and Sridevi, S and Thota, Balaram and Srividya, Mallavarapu R and Prasanna, K and Thennarasu, K and Mondal, Neelima and Hegde, AS and Chandramouli, BA and Santosh, V and Rao, MRS and Kondaiah, P and Somasundaram, K (2012) Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor. In: JOURNAL OF NEURO-ONCOLOGY, 107 (2). pp. 289-297.
Kumar, Durairaj Mohan and Thota, Balaram and Shinde, Sridevi Vijay and Prasanna, KV and Hegde, AS and Arivazhagan, A and Chandramouli, BA and Santosh, Vani and Somasundaram, Kumaravel (2010) Proteomic Identification of Haptoglobin alpha 2 as a Glioblastoma Serum Biomarker: Implications in Cancer Cell Migration and Tumor Growth. In: Journal of Proteome Research, 9 (11). pp. 5557-5567.
Somasundaram, Kumaravel and Nijaguna, Mamatha B and Kumar, Durairaj Mohan (2009) Serum proteomics of glioma: methods and applications. In: Expert Review of Molecular Diagnostics, 9 (7). pp. 695-707.